Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

Biedermann L, Renz L, Fournier N, Rossel JB, Butter M, Bluemel S, Vavricka SR, Rogler G, Scharl M.

Therap Adv Gastroenterol. 2019 Aug 13;12:1756284819865142. doi: 10.1177/1756284819865142. eCollection 2019.

2.

Adapting the Canadian CT head rule age criteria for mild traumatic brain injury.

Fournier N, Gariepy C, Prévost JF, Belhumeur V, Fortier É, Carmichael PH, Gariepy JL, Le Sage N, Émond M.

Emerg Med J. 2019 Oct;36(10):617-619. doi: 10.1136/emermed-2018-208153. Epub 2019 Jul 20.

PMID:
31326953
3.

Pain Intensity in the First 96 Hours After Abdominal Surgery: A Prospective Cohort Study.

Cachemaille M, Grass F, Fournier N, Suter MR, Demartines N, Hübner M, Blanc C.

Pain Med. 2019 Jul 19. pii: pnz156. doi: 10.1093/pm/pnz156. [Epub ahead of print]

PMID:
31322667
4.

Spatial exploration induced expression of immediate early genes Fos and Zif268 in adult-born neurons Is reduced after pentylenetetrazole kindling.

Kalinina A, Maletta T, Carr J, Lehmann H, Fournier NM.

Brain Res Bull. 2019 Oct;152:74-84. doi: 10.1016/j.brainresbull.2019.07.003. Epub 2019 Jul 4.

PMID:
31279580
5.

Effects of first-generation in utero exposure to diesel engine exhaust on second-generation placental function, fatty acid profiles and foetal metabolism in rabbits: preliminary results.

Rousseau-Ralliard D, Valentino SA, Aubrière MC, Dahirel M, Lallemand MS, Archilla C, Jouneau L, Fournier N, Richard C, Aioun J, Vitorino Carvalho A, Jérôme L, Slama R, Duranthon V, Cassee FR, Chavatte-Palmer P, Couturier-Tarrade A.

Sci Rep. 2019 Jul 4;9(1):9710. doi: 10.1038/s41598-019-46130-x.

6.

Impairment in behavioral sedation in rats during periods of elevated global geomagnetic activity.

Fournier NM.

Int J Biometeorol. 2019 Sep;63(9):1243-1249. doi: 10.1007/s00484-019-01741-x. Epub 2019 Jun 17.

PMID:
31209598
7.

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.

Hiller A, Biedermann L, Fournier N, Butter M, Vavricka SR, Ciurea A, Rogler G, Scharl M; Swiss IBD Cohort Study Group.

PLoS One. 2019 Apr 30;14(4):e0211554. doi: 10.1371/journal.pone.0211554. eCollection 2019.

8.

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.

Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J; Swiss IBD Cohort Study Group.

PLoS One. 2019 Apr 25;14(4):e0215738. doi: 10.1371/journal.pone.0215738. eCollection 2019.

9.

Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.

Schoepfer A, Santos J, Fournier N, Schibli S, Spalinger J, Vavricka S, Safroneeva E, Aslan N, Rogler G, Braegger C, Nydegger A.

J Crohns Colitis. 2019 Sep 27;13(10):1334-1342. doi: 10.1093/ecco-jcc/jjz065.

PMID:
31002741
10.

Dose-response relationship of perineural dexamethasone for interscalene brachial plexus block: a randomised, controlled, triple-blind trial.

Albrecht E, Reynvoet M, Fournier N, Desmet M.

Anaesthesia. 2019 Aug;74(8):1001-1008. doi: 10.1111/anae.14650. Epub 2019 Apr 11.

PMID:
30973188
11.

Effect of Pre-Hospital Intubation in Patients with Severe Traumatic Brain Injury on Outcome: A Prospective Cohort Study.

Choffat C, Delhumeau C, Fournier N, Schoettker P.

J Clin Med. 2019 Apr 6;8(4). pii: E470. doi: 10.3390/jcm8040470.

12.

Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile.

Gujer C, Murer A, Müller A, Vanoaica D, Sutter K, Jacque E, Fournier N, Kalchschmidt J, Zbinden A, Capaul R, Dzionek A, Mondon P, Dittmer U, Münz C.

Blood Adv. 2019 Apr 9;3(7):1129-1144. doi: 10.1182/bloodadvances.2018025536.

13.

Investigation of lipid modifications in J774 macrophages by vibrational spectroscopies after eicosapentaenoic acid membrane incorporation in unloaded and cholesterol-loaded cells.

Tfaili S, Al Assaad A, Fournier N, Allaoui F, Paul JL, Chaminade P, Tfayli A.

Talanta. 2019 Jul 1;199:54-64. doi: 10.1016/j.talanta.2019.01.122. Epub 2019 Feb 12.

PMID:
30952295
14.

Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.

Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L.

J Crohns Colitis. 2019 Sep 27;13(10):1292-1301. doi: 10.1093/ecco-jcc/jjz057.

PMID:
30854548
15.

Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.

Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators, Wiest R, Stelling J, Macpherson AJ.

Nat Med. 2019 Apr;25(4):701. doi: 10.1038/s41591-019-0411-9.

PMID:
30846883
16.

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies.

Bas M, Terrier A, Jacque E, Dehenne A, Pochet-Béghin V, Beghin C, Dezetter AS, Dupont G, Engrand A, Beaufils B, Mondon P, Fournier N, de Romeuf C, Jorieux S, Fontayne A, Mars LT, Monnet C.

J Immunol. 2019 Mar 1;202(5):1582-1594. doi: 10.4049/jimmunol.1800896. Epub 2019 Jan 25.

PMID:
30683704
17.

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group.

PLoS One. 2019 Jan 25;14(1):e0210436. doi: 10.1371/journal.pone.0210436. eCollection 2019.

18.

Microbial network disturbances in relapsing refractory Crohn's disease.

Yilmaz B, Juillerat P, Øyås O, Ramon C, Bravo FD, Franc Y, Fournier N, Michetti P, Mueller C, Geuking M, Pittet VEH, Maillard MH, Rogler G; Swiss IBD Cohort Investigators, Wiest R, Stelling J, Macpherson AJ.

Nat Med. 2019 Feb;25(2):323-336. doi: 10.1038/s41591-018-0308-z. Epub 2019 Jan 21. Erratum in: Nat Med. 2019 Apr;25(4):701.

PMID:
30664783
19.

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.

Pittet VEH, Maillard MH, Simonson T, Fournier N, Rogler G, Michetti P; Swiss IBD Cohort Study Group(∗).

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2050-2059.e1. doi: 10.1016/j.cgh.2018.11.029. Epub 2018 Nov 22.

PMID:
30471455
20.

A short periconceptional exposure to maternal type-1 diabetes is sufficient to disrupt the feto-placental phenotype in a rabbit model.

Rousseau-Ralliard D, Couturier-Tarrade A, Thieme R, Brat R, Rolland A, Boileau P, Aubrière MC, Daniel N, Dahirel M, Derisoud E, Fournier N, Schindler M, Duranthon V, Fischer B, Santos AN, Chavatte-Palmer P.

Mol Cell Endocrinol. 2019 Jan 15;480:42-53. doi: 10.1016/j.mce.2018.10.010. Epub 2018 Oct 9.

PMID:
30308265
21.

Dexamethasone Is Superior to Dexmedetomidine as a Perineural Adjunct for Supraclavicular Brachial Plexus Block: Systematic Review and Indirect Meta-analysis.

Albrecht E, Vorobeichik L, Jacot-Guillarmod A, Fournier N, Abdallah FW.

Anesth Analg. 2019 Mar;128(3):543-554. doi: 10.1213/ANE.0000000000003860.

PMID:
30303864
22.

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Greuter T, Piller A, Fournier N, Safroneeva E, Straumann A, Biedermann L, Godat S, Nydegger A, Scharl M, Rogler G, Vavricka SR, Schoepfer AM; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2018 Nov 28;12(12):1399-1409. doi: 10.1093/ecco-jcc/jjy121.

PMID:
30165603
23.

Surgical teaching does not increase the risk of intraoperative adverse events.

Pache B, Grass F, Fournier N, Hübner M, Demartines N, Hahnloser D.

Int J Colorectal Dis. 2018 Dec;33(12):1715-1722. doi: 10.1007/s00384-018-3143-2. Epub 2018 Aug 24.

PMID:
30143855
24.

Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.

Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1159-1167. doi: 10.1097/MEG.0000000000001197.

PMID:
29985208
25.

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.

Yilmaz B, Spalinger MR, Biedermann L, Franc Y, Fournier N, Rossel JB, Juillerat P, Rogler G, Macpherson AJ, Scharl M.

PLoS One. 2018 Jul 2;13(7):e0199664. doi: 10.1371/journal.pone.0199664. eCollection 2018.

26.

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1768-1779. doi: 10.1093/ibd/izy054.

27.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group .

J Crohns Colitis. 2018 Jun 28;12(7):811-818. doi: 10.1093/ecco-jcc/jjy040.

PMID:
29617750
28.

Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.

Fournier N, Jacque E, Fontayne A, Derache D, Dupont G, Verhaeghe L, Baptista L, Dehenne A, Dezetter AS, Terrier A, Longue A, Pochet-Beghin V, Beghin C, Chtourou S, de Romeuf C.

MAbs. 2018 May/Jun;10(4):651-663. doi: 10.1080/19420862.2018.1451283. Epub 2018 Apr 10.

29.

Pain perception after colorectal surgery: A propensity score matched prospective cohort study.

Grass F, Cachemaille M, Martin D, Fournier N, Hahnloser D, Blanc C, Demartines N, Hübner M.

Biosci Trends. 2018;12(1):47-53. doi: 10.5582/bst.2017.01312.

30.

Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.

Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):612-620. doi: 10.1097/MEG.0000000000001078.

31.

Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.

Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Spalinger J, Schibli S, Petit LM, Braegger CP; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):598-607. doi: 10.1097/MEG.0000000000001072.

PMID:
29360691
32.

Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.

Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.

Digestion. 2017 Nov;96(4):220-227. doi: 10.1159/000482007. Epub 2017 Oct 24.

33.

Eicosapentaenoic acid membrane incorporation impairs cholesterol efflux from cholesterol-loaded human macrophages by reducing the cholesteryl ester mobilization from lipid droplets.

Fournier N, Sayet G, Vedie B, Nowak M, Allaoui F, Solgadi A, Caudron E, Chaminade P, Benoist JF, Paul JL.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Oct;1862(10 Pt A):1079-1091. doi: 10.1016/j.bbalip.2017.07.011. Epub 2017 Jul 21.

PMID:
28739279
34.

The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease.

Sokollik C, Fournier N, Rizzuti D, Braegger CP, Nydegger A, Schibli S, Spalinger J; Swiss IBD Cohort Study Group.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):e87-e91. doi: 10.1097/MCG.0000000000000864.

35.

Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.

Herzog D, Fournier N, Buehr P, Rueger V, Koller R, Heyland K, Nydegger A, Braegger CP; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2017 Aug;29(8):926-931. doi: 10.1097/MEG.0000000000000896.

36.

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Vavricka SR, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N, Juillerat P, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Heinrich H, Manser CN, Safroneeva E, Raja Ali RA, Rogler G, Schoepfer AM, Greuter T; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2017 Jul;23(7):1174-1181. doi: 10.1097/MIB.0000000000001109.

37.

A randomised controlled trial of placebo, droperidol or ondansetron to prevent nausea and vomiting after tonsillectomy in children receiving dexamethasone.

Flubacher P, Fournier N, Cherpillod J, Waridel F, Nydegger M, Albrecht E.

Anaesthesia. 2017 Jul;72(7):859-863. doi: 10.1111/anae.13907. Epub 2017 Apr 27.

38.

Reduced hemidiaphragmatic paresis with extrafascial compared with conventional intrafascial tip placement for continuous interscalene brachial plexus block: a randomized, controlled, double-blind trial.

Albrecht E, Bathory I, Fournier N, Jacot-Guillarmod A, Farron A, Brull R.

Br J Anaesth. 2017 Apr 1;118(4):586-592. doi: 10.1093/bja/aex050.

39.

Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort.

Zeitz J, Fournier N, Labenz C, Biedermann L, Frei P, Misselwitz B, Scharl S, Vavricka SR, Sulz MC, Fried M, Rogler G, Scharl M.

Inflamm Intest Dis. 2017 Apr;1(4):172-181. doi: 10.1159/000458144. Epub 2017 Feb 25.

40.

Mycophenolate Mofetil and Rapamycin Induce Apoptosis in the Human Monocytic U937 Cell Line Through Two Different Pathways.

Nowak M, Tardivel S, Nguyen-Khoa T, Abreu S, Allaoui F, Fournier N, Chaminade P, Paul JL, Lacour B.

J Cell Biochem. 2017 Oct;118(10):3480-3487. doi: 10.1002/jcb.26007. Epub 2017 Apr 24.

PMID:
28345768
41.

A mixed methods investigation of bicycle exposure in crash rates.

Fournier N, Christofa E, Knodler MA Jr.

Accid Anal Prev. 2019 Sep;130:54-61. doi: 10.1016/j.aap.2017.02.004. Epub 2017 Mar 1.

PMID:
28259202
42.

Is standardized care feasible in the emergency setting? A case matched analysis of patients undergoing laparoscopic cholecystectomy.

Grass F, Cachemaille M, Blanc C, Fournier N, Halkic N, Demartines N, Hübner M.

BMC Surg. 2016 Dec 1;16(1):78.

43.

Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: Results of a randomized controlled trial.

de Roten Y, Ambresin G, Herrera F, Fassassi S, Fournier N, Preisig M, Despland JN.

J Affect Disord. 2017 Feb;209:105-113. doi: 10.1016/j.jad.2016.11.013. Epub 2016 Nov 17.

44.

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.

Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, Nydegger A, Vavricka SR, Moradpour D, Schoepfer AM; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2017 Jan;29(1):91-97.

45.

Increased task demand during spatial memory testing recruits the anterior cingulate cortex.

Carr JK, Fournier NM, Lehmann H.

Learn Mem. 2016 Aug 16;23(9):450-4. doi: 10.1101/lm.042366.116. Print 2016 Sep.

46.

Maternal exposure to diluted diesel engine exhaust alters placental function and induces intergenerational effects in rabbits.

Valentino SA, Tarrade A, Aioun J, Mourier E, Richard C, Dahirel M, Rousseau-Ralliard D, Fournier N, Aubrière MC, Lallemand MS, Camous S, Guinot M, Charlier M, Aujean E, Al Adhami H, Fokkens PH, Agier L, Boere JA, Cassee FR, Slama R, Chavatte-Palmer P.

Part Fibre Toxicol. 2016 Jul 26;13(1):39. doi: 10.1186/s12989-016-0151-7.

47.

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.

Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M, Rogler G, Vavricka S; Swiss IBD Cohort Study Group.

PLoS One. 2016 Jun 22;11(6):e0156666. doi: 10.1371/journal.pone.0156666. eCollection 2016.

48.

Using an inertial navigation algorithm and accelerometer to monitor chest compression depth during cardiopulmonary resuscitation.

Boussen S, Ibouanga-Kipoutou H, Fournier N, Raboutet YG, Llari M, Bruder N, Arnoux PJ, Behr M.

Med Eng Phys. 2016 Sep;38(9):1028-34. doi: 10.1016/j.medengphy.2016.05.001. Epub 2016 May 28.

PMID:
27246666
49.

Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.

Alatri A, Schoepfer A, Fournier N, Engelberger RP, Safroneeva E, Vavricka S, Biedermann L, Calanca L, Mazzolai L; Swiss IBD Cohort Study Group.

Scand J Gastroenterol. 2016 Oct;51(10):1200-5. doi: 10.1080/00365521.2016.1185464. Epub 2016 May 20.

PMID:
27211077
50.

Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.

Schoepfer AM, Vavricka S, Safroneeva E, Fournier N, Manser C, Frei P, Deltenre P, Rogler G, Straumann A, Ezri J, Nydegger A, Braegger C.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):245-247. doi: 10.1097/MPG.0000000000001238.

Supplemental Content

Loading ...
Support Center